Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Neovoca Ltd

Neovoca Ltd is a consultancy founded on the belief that the patient is the first customer, and that the goals of industry, healthcare professionals and society, all meet with the aim of improved patient care. To consistently achieve this requires a legitimate and valuable dialogue between the healthcare industry and the consumer. Our Mission, is to help build those conversations by working across the public and private sectors, and our services are centred on helping the pharmaceutical industry achieve a stronger and considered conversation with those consumers who should be benefiting from years of painstaking and rigorous research.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs

- PMLiVE

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Advertising, Branding, Creative and design, Digital communications, Management consultancies, Marketing consultancies, Media planning and buying, Medical communications, Medical education, Patient support and adherence, Public relations

- PMLiVE

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

Branding, Creative and design, Management consultancies, Market access, Market research, Media planning and buying, Medical communications, Medical education, Public relations

OPEN Health

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Advertising, Branding, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Medical education, Patient support and adherence, Public relations, Training

Sciterion Logo

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs

Company Details

Neovoca Ltd
The Counting House, Tring, HP23 5TE, United Kingdom
07786 126686
Contact Neovoca Ltd
Website

 Latest Content from PMHub 

Fishawack Health expands its value, evidence, and market access capabilities with the acquisition of HEOR consultancy Policy Analysis Inc. (PAI)

Press Releases | March 3, 2022 | Avalere Health

Fishawack Health announces its expanded global Value, Evidence, and Access (VEA) capability for biopharmaceutical and medical technology companies, with a suite of end-to-end services spanning product lifecycle, coupled with unsurpassed...

Onyx Health Announces a “Double Hatrick” of New Appointments

Press Releases | March 3, 2022 | Onyx Health

Onyx Health continues to expand with six new appointments to its creative and communication teams, due to increased growth in its international client portfolio work.

Utilising Patient Insight in Pharma Marketing

White Papers and Resources | March 3, 2022 | Dice Medical Communications

The importance in understanding the patients view point when marketing in Pharma (Article written August 30th 2021)

Office move signals new era for Berkshire agency

Press Releases | March 3, 2022 | Dice Medical Communications

Dice Medical Communications moves office due to business growth

How Ease of Access to HES Data Benefits HCPs & Key NHS Stakeholders

White Papers and Resources | March 3, 2022 | Dice Medical Communications

Article written August 27th 2021

How a Copywriter Reads a Clinical Paper

White Papers and Resources | March 2, 2022 | Dice Medical Communications

What key elements you need to consider in a clinical paper (Article written November 18th 2021)

What does HCP engagement look like in a post-Covid world?

White Papers and Resources | March 2, 2022 | Dice Medical Communications

HCP engagement has changed as a result of the Covid-19 pandemic, with pharmaceutical companies and agencies having to rapidly adjust to a new way of communicating. Digital channels have become...

Placing people at Lucid’s heart: Paul Cutler, Lucid Group’s new Chief People Officer

Press Releases | March 2, 2022 | Lucid Group Communications Limited

We interviewed Paul Cutler, Lucid Group’s new Chief People Officer, to find out a bit more about what makes him tick, why he chose to join Lucid, and what his...

Nucleus Global launches new branding as it sets its sights on the future

Press Releases | March 1, 2022 | Nucleus Global

Nucleus Global, the largest specialist medical communications network in the world, has announced the launch of its new brand.With over 35 years of experience providing medical communications excellence to the...

White paper: Are we prepared for the influx of CAR-Ts?

White Papers and Resources | March 1, 2022 | Inizio

Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies